ClassID:

20900

A61K38/08 - page 5 - CPC Classification

Classification description:

Medicinal preparations containing peptides; Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof Peptides having 5 to 11 amino acids

Recent Application in this class:
#1201
20190119320
2019-04-25

Inhibitors of metastasis

#1202
20190117749
2019-04-25

PEPTIDE VACCINE THERAPY FOR TREATMENT OF FRa-EXPRESSING TUMORS

#1203
20190117725
2019-04-25

Inhibition of TREM receptor signaling with peptide variants

#1204
20190112339
2019-04-18

BK channel-modulating peptides and their use

#1205
20190112338
2019-04-18

Decoy peptides inhibiting protein phosphatase 1-medicated dephosphorylation of phospholamban

#1206
20190111120
2019-04-18

NOVEL CANCER ANTIGEN EEF2

#1207
20190111112
2019-04-18

Chondrocyte extracellular matrix-derived peptide

#1208
20190111104
2019-04-18

Neuroprotective peptide

#1209
20190106460
2019-04-11

BINDING INHIBITORS OF THE BETA. TRANSDUCIN REPEAT-CONTAINING PROTEIN

#1210
20190100599
2019-04-04

Nanobody dimers linked via C-terminally engineered cysteins

#1211
20190100572
2019-04-04

Chondrocyte extracellular matrix-derived peptide

#1212
20190100559
2019-04-04

Gamma-AApeptides with potent and broad-spectrum antimicrobial activity

#1213
20190100556
2019-04-04

Peptide with anti-obesity and anti-diabetic efficacy and use thereof

#1214
20190092830
2019-03-28

Interleukin 15 fusion protein for tumor targeting therapy

#1215
20190092821
2019-03-28

Peptide exhibiting hair growth promoting activity and/or melanin production promoting activity and use thereof

#1216
20190092816
2019-03-28

Stapled peptides and uses thereof

#1217
20190091494
2019-03-28

PEPTIDES FOR HAIR GROWTH

#1218
20190091345
2019-03-28

Anti-HER2 antibody-drug conjugate and application thereof

#1219
20190091312
2019-03-28

Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers

#1220
20190091285
2019-03-28

Oral octreotide administered in combination with other therapeutic agents

#1221
20190091284
2019-03-28

Amidated Dopamine Neuron Stimulating Peptides for CNS Dopaminergic Upregulation

#1222
20190091282
2019-03-28

PEPTIDES FOR USE IN PROMOTING TRANSPORT OF GLUCOSE

#1223
20190091281
2019-03-28

DELIVERY PHARMACEUTICAL COMPOSITIONS INCLUDING PERMEATION ENHANCERS

#1224
20190091280
2019-03-28

Polymeric nanoparticles and a process of preparation thereof

#1225
20190091279
2019-03-28

METHODS FOR REDUCING PERINATAL MORBIDITY AND/OR MORTALITY

#1226
20190091278
2019-03-28

Peptide having anti-inflammatory activity, and use thereof

#1227
20190085030
2019-03-21

D-enantiomeric peptides derived from D3 and use thereof

#1228
20190083592
2019-03-21

IMMUNOSTIMULATORY COMBINATIONS

#1229
20190083580
2019-03-21

Use of endostatin peptides for the treatment of fibrosis

#1230
20190083408
2019-03-21

Controlled-release peptide compositions and uses thereof

#1231
20190077831
2019-03-14

Connective tissue stimulating peptides

#1232
20190076556
2019-03-14

Compositions for neuromodulation of mosquito feeding behavior and uses thereof

#1233
20190076548
2019-03-14

Compositions and methods for the depletion of CD137+ cells

#1234
20190076538
2019-03-14

Cholecystokinin B receptor targeting for imaging and therapy

#1235
20190076400
2019-03-14

Opioid agonist peptides and uses thereof

#1236
20190071478
2019-03-07

Peptide having hair growth-promoting activity and/or melanin generation-promoting activity, and use thereof

#1237
20190070249
2019-03-07

Method of treatment or prophylaxis of infections of the eye

#1238
20190070248
2019-03-07

Peptide mimotopes of the CD3 T-cell co-receptor epsilon chain and uses thereof

#1239
20190070168
2019-03-07

GAP JUNCTION-ENHANCING AGENTS FOR TREATMENT OF NECROTIZING ENTEROCOLITIS AND INFLAMMATORY BOWEL DISEASE

#1240
20190062375
2019-02-28

Composition for overcoming resistance to EGFR-targeting agent

#1241
20190062371
2019-02-28

PEPTIDE COMPOSITIONS AND RELATED METHODS

#1242
20190060431
2019-02-28

Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers

#1243
20190060240
2019-02-28

Storage stable sincalide formulations

#1244
20190060239
2019-02-28

Technology for the Preparation of Microparticles

#1245
20190055287
2019-02-21

Polypeptide, DNA molecule encoding the polypeptide, vector, preparation method and use

#1246
20190054143
2019-02-21

Anti-SSX-2 T cell receptors and related materials and methods of use

#1247
20190054137
2019-02-21

Peptides and methods for treatment of neurodegenerative diseases

#1248
20190048086
2019-02-14

ANTI-CITRULLINATED HLA POLYPEPTIDE ANTIBODIES AND USES THEREOF

#1249
20190048073
2019-02-14

ANTI-GD3 ANTIBODIES AND ANTIBODY-DRUG CONJUGATES

#1250
20190046601
2019-02-14

Peptides Having Anti-Inflammatory Properties

#1251
20190040101
2019-02-07

Compound for treating sequelae of ischemic cerebral stroke

#1252
20190038760
2019-02-07

CO-ADMINISTRATION OF AN AGENT LINKED TO AN INTERNALIZATION PEPTIDE WITH AN ANTI-INFLAMMATORY

#1253
20190038758
2019-02-07

PHARMACEUTICAL COMPOSITIONS AND RELATED METHODS OF DELIVERY

#1254
20190033318
2019-01-31

HIF-1 and HIF-2 inhibitors

#1255
20190030115
2019-01-31

Peptide analogues with branched amino acid probe(s)

#1256
20190023762
2019-01-24

Peptides and combination of peptides for use in immunotherapy against various tumors

#1257
20190023748
2019-01-24

D-peptide inhibitors of HIV entry and methods of use

#1258
20190023740
2019-01-24

Inhibitors of beta integrin-G protein alpha subunit binding interactions

#1259
20190022170
2019-01-24

Compositions containing a pharmacophore with selectivity to diseased tissue and methods of making same

#1260
20190022168
2019-01-24

Methods of lowering blink reflex for the treatment of dry eye disease

#1261
20190022167
2019-01-24

METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY

#1262
20190022166
2019-01-24

ORAL ANTI-INFLAMMATORY PEPTIDES TO TREAT EPILEPSY, SEIZURES AND CNS DISORDERS

#1263
20190010247
2019-01-10

Therapeutic antibodies and uses thereof

#1264
20190010185
2019-01-10

Method for synthesizing etelcalcetide

#1265
20190002559
2019-01-03

Antibodies specific for Trop-2 and their uses

#1266
20190002528
2019-01-03

Pharmaceutical composition for preventing or treating dry eyes

#1267
20190002524
2019-01-03

Peptides and combination of peptides for use in immunotherapy against various tumors

#1268
20190002502
2019-01-03

Cell-permeable inhibitory agent and methods of use thereof in treatment of cognitive and mood disorders

#1269
20190000983
2019-01-03

AN EYE DROP SOLUTION FOR ENHANCED HYALURONIC ACID RETENTION AND DELIVERY

#1270
20190000918
2019-01-03

Octreotide injection

#1271
20190000916
2019-01-03

Compositions and methods for modulating AT2R activity

#1272
20180369452
2018-12-27

Combination compositions

#1273
20180369405
2018-12-27

Methods of producing drug-carrying polymer scaffolds and protein-polymer-drug conjugates

#1274
20180369397
2018-12-27

Method of making sulfur-containing polymers from hexahydrotriazine and dithiol precursors

#1275
20180369319
2018-12-27

Method of Reducing Injury to Mammalian Cells

#1276
20180369115
2018-12-27

Compounds useful in the treatment and/or care of the skin, hair, nails, and/or mucous membranes

#1277
20180362582
2018-12-20

Macrocyclic compounds and methods of preventing or treating pain

#1278
20180360985
2018-12-20

CD38 antibody drug conjugate

#1279
20180360979
2018-12-20

Bioorthogonal compositions

#1280
20180360907
2018-12-20

Anti-inflammatory peptides for treating non-alcoholic steatohepatitis (NASH)

#1281
20180360904
2018-12-20

Hemostatic composition and hemostatic method using hemostatic composition

#1282
20180360720
2018-12-20

Anti-aging peptide, its composition and method of using the same

#1283
20180353566
2018-12-13

Phosphorylcholine conjugates and uses thereof

#1284
20180353565
2018-12-13

PHARMACEUTICAL FORMULATIONS AND THEIR USE FOR THE TREATMENT OF RETINITIS PIGMENTOSA

#1285
20180346548
2018-12-06

Peptides and combination of peptides for use in immunotherapy against various tumors

#1286
20180346535
2018-12-06

Anti-amyloid beta antibodies binding to a cyclic amyloid beta peptide

#1287
20180344864
2018-12-06

COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF TUMOR

#1288
20180344803
2018-12-06

Methods and Compositions For the Treatment of Proteinuric Diseases

#1289
20180344798
2018-12-06

TOPICALLY ACTIVE PEPTIDES FOR TREATING COSMETIC AND DERMATOLOGICAL CONDITIONS

#1290
20180340019
2018-11-29

Peptides and combination of peptides for use in immunotherapy against various tumors

#1291
20180339013
2018-11-29

Collagenase-derived peptides promote tissue regeneration and wound healing

#1292
20180333451
2018-11-22

B-1A LYMPHOCYTE AND/OR MACROPHAGE TARGETING AND ACTIVATION TO TREAT MEDICAL CONDITIONS WITH INFLAMMATORY OR AUTOIMMUNE COMPONENTS

#1293
20180327475
2018-11-15

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

#1294
20180327468
2018-11-15

Histatins and method of use thereof

#1295
20180327454
2018-11-15

PEPTIDE PHARMACEUTICALS

#1296
20180327452
2018-11-15

COMPOSITION FOR IMPROVING MEMORY, LEARNING ABILITY, AND COGNITIVE ABILITY

#1297
20180327451
2018-11-15

Composition for improving memory, learning ability, and cognitive ability

#1298
20180327367
2018-11-15

MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS

#1299
20180326079
2018-11-15

Fatty acids and their use in conjugation to biomolecules

#1300
20180325811
2018-11-15

Composition for treating apoplexy through nasal administration

#1301
20180323088
2018-11-08

Die placement head with turret

#1302
20180319868
2018-11-08

Serpin reactive center loop peptides and methods of use

#1303
20180319856
2018-11-08

Anti-amyloid beta antibodies binding to a cyclic amyloid beta peptide

#1304
20180319848
2018-11-08

Modifications of cupredoxin derived peptides

#1305
20180319840
2018-11-08

Antimicrobial peptide and use thereof

#1306
20180318429
2018-11-08

Use of hydrophobic organic acids to increase hydrophobicity of proteins and protein conjugates

#1307
20180318382
2018-11-08

Therapy and kit for the prevention and treatment of cystic fibrosis

#1308
20180312605
2018-11-01

Antibodies against the MUC1-C/extracellular domain (MUC1-C/ECD)

#1309
20180312541
2018-11-01

Dual-site BACE1 inhibitors

#1310
20180312540
2018-11-01

Method of treating Alzheimer's disease

#1311
20180311360
2018-11-01

Sprayable topical carrier and composition comprising phosphatidylcholine

#1312
20180311310
2018-11-01

Therapeutic and diagnostics compositions targeting toll-like receptors and methods thereof

#1313
20180311305
2018-11-01

Low-burst polymers and methods to produce polymer

#1314
20180311304
2018-11-01

Methods for the treatment of depression and anxiety by a melanocortin 5 receptor antagonist, PG-20N

#1315
20180303956
2018-10-25

Liposomes containing cell penetrating peptides and tetraetherlipids for the oral delivery of macromolecules

#1316
20180303951
2018-10-25

Glycotargeting therapeutics

#1317
20180303921
2018-10-25

Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers

#1318
20180303920
2018-10-25

Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers

#1319
20180303919
2018-10-25

Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers

#1320
20180303902
2018-10-25

ENGINEERED INTEGRIN BINDING PEPTIDE COMPOSITIONS

#1321
20180303898
2018-10-25

Compositions for delivery to and treatment of atherosclerotic plaques

#1322
20180298057
2018-10-18

Compositions and methods for managing respiratory conditions

#1323
20180296681
2018-10-18

Peptide pharmaceuticals

#1324
20180296675
2018-10-18

Combination therapies for treatment of cancer

#1325
20180296637
2018-10-18

METHODS OF DIAGNOSING AND TREATING VASCULAR ASSOCIATED MACULOPATHY AND SYMPTOMS THEREOF

#1326
20180296631
2018-10-18

HYDROGEL COMPOSITION AND ASSOCIATED METHOD OF USE

#1327
20180296456
2018-10-18

Decapeptide-12 Modulation of Sirtuin Gene Expression in Epidermal Keratinocyte Progenitors

#1328
20180291085
2018-10-11

Compositions Comprising D-Amino Acid Peptides and Methods of Production and Use Thereof for Inhibiting Autoantibodies

#1329
20180291082
2018-10-11

Peptides and combination thereof for use in the immunotherapy against cancers

#1330
20180291064
2018-10-11

Methods and compositions for the treatment of arthritis

#1331
20180291061
2018-10-11

Peptides of use in the preventive and curative treatment of alopecia

#1332
20180289832
2018-10-11

Compositions and methods for the depletion of CD137+ cells

#1333
20180289826
2018-10-11

CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS

#1334
20180289769
2018-10-11

Methods and compositions comprising desmopressin in combination with a beta-3-adrenergic receptor agonist

#1335
20180289767
2018-10-11

Compositions and methods for invasive and non-invasive procedural skincare

#1336
20180289395
2018-10-11

Recovery and processing of human embryos formed in vivo

#1337
20180282373
2018-10-04

Peptide-based inhibitors of MLL/SET1 family core complexes

#1338
20180282371
2018-10-04

Protein based adhesive composition and method

#1339
20180280520
2018-10-04

Compositions and methods related to inhibition of respiratory syncytial virus entry

#1340
20180280481
2018-10-04

Pharmaceutical formulations for the oral delivery of peptide drugs

#1341
20180280469
2018-10-04

Pharmaceutical formulations of desmopressin

#1342
20180280466
2018-10-04

Phosphorylcholine conjugates and uses thereof

#1343
20180271991
2018-09-27

CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS

#1344
20180271933
2018-09-27

Anti-androgen peptides and uses thereof in cancer therapy

#1345
20180271932
2018-09-27

METHODS OF TREATING CELIAC DISEASE WITH LARAZOTIDE

#1346
20180271931
2018-09-27

P75antagonists and treatment of acute and chronic cardiac disease

#1347
20180265548
2018-09-20

Ligands for integrin αvβ6, synthesis and uses thereof

#1348
20180264130
2018-09-20

TARGETING THE M2-TUMOR ASSOCIATED MACROPHAGE FOR CANCER THERAPY

#1349
20180264126
2018-09-20

Compound with effects of thrombolysis, free radical scavenging and thrombus-targeting

#1350
20180264079
2018-09-20

Immune checkpoint inhibitor combinations

#1351
20180264073
2018-09-20

Pharmaceutical compositions of water soluble peptides with poor solubility in isotonic conditions and methods for their use

#1352
20180263909
2018-09-20

DUAL LOADED LIPOSOMAL NANOPARTICLES

#1353
20180258155
2018-09-13

RELAXIN1 derived peptides for use in immunotherapy against various tumors

#1354
20180256737
2018-09-13

Conjugates for treating diseases caused by PSMA expressing cells

#1355
20180256736
2018-09-13

CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS

#1356
20180256735
2018-09-13

CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS

#1357
20180256734
2018-09-13

CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS

#1358
20180256733
2018-09-13

CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS

#1359
20180256732
2018-09-13

Glycoprotein-toxic payload conjugates

#1360
20180256724
2018-09-13

Hydrogels for delivery of therapeutic compounds

#1361
20180251518
2018-09-06

Peptides and combination of peptides for use in immunotherapy against various tumors

#1362
20180251517
2018-09-06

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

#1363
20180250353
2018-09-06

CEACAM based antibacterial agents

#1364
20180243480
2018-08-30

MESENCHYMAL CELL-BINDING COMPOSITE MATERIAL FOR TISSUE RESTORATION

#1365
20180243433
2018-08-30

Block copolymers

#1366
20180243363
2018-08-30

NEUROKININ 1 RECEPTOR AGONIST MEDIATED PROTECTION OF THE EYE

#1367
20180237494
2018-08-23

Peptides and combination of peptides for use in immunotherapy against various tumors

#1368
20180237493
2018-08-23

Peptides and combination of peptides for use in immunotherapy against various tumors

#1369
20180237485
2018-08-23

Cell-permeable bone morphogenetic protein (CP-BMP) recombinant protein and use thereof

#1370
20180236002
2018-08-23

Compositions and methods for treating graft versus host disease

#1371
20180230195
2018-08-16

Peptides and combination of peptides for use in immunotherapy against various tumors

#1372
20180230194
2018-08-16

Peptides and combination of peptides for use in immunotherapy against various tumors

#1373
20180230191
2018-08-16

Compounds, compositions and uses thereof for improvement of bone disorders

#1374
20180228941
2018-08-16

PHARMACEUTICAL COMPOSITION, SUBSTRATE COMPRISING A PHARMACEUTICAL COMPOSITION, AND USE OF A PHARMACEUTICAL COMPOSITION

#1375
20180228865
2018-08-16

Peptide for preventing or treating inflammatory diseases and use thereof

#1376
20180222949
2018-08-09

Functionalized protein-based materials and their uses

#1377
20180222858
2018-08-09

DERIVATIVES OF DOLASTATIN 10 AND AURISTATINS

#1378
20180221391
2018-08-09

Synthetic bile acid compositions and methods

#1379
20180215788
2018-08-02

Compounds and Compositions for the Treatment of Ophthalmic Disorders

#1380
20180214612
2018-08-02

Three-dimensional tissue scaffold with stem cell attracting element and use thereof

#1381
20180214582
2018-08-02

METHOD FOR DIAGNOSING CARCINOMAS USING IRGD AND MAGENTIC RESONANCE TOMOGRAPHY (MRT)

#1382
20180214557
2018-08-02

Carrier molecule compositions and related methods

#1383
20180208641
2018-07-26

Peptides and combination of peptides for use in immunotherapy against various tumors

#1384
20180208640
2018-07-26

Peptides and combination of peptides for use in immunotherapy against various tumors

#1385
20180208626
2018-07-26

Immunogenic WT-1 peptides and methods of use thereof

#1386
20180207227
2018-07-26

Therapeutic and Neuroprotective Peptides

#1387
20180207226
2018-07-26

Compositions and methods for inhibition of bacterial infections in human endocervix

#1388
20180201651
2018-07-19

PHARMACEUTICAL COMPOSITION THAT IS ANTICANCER AND SUPPRESSES CANCER METASTASIS, CONTAINING, AS ACTIVE INGREDIENT, FUSION PEPTIDE SIMULTANEOUSLY TARGETING CANCER CELL AND TUMOR ASSOCIATED MACROPHAGE

#1389
20180200378
2018-07-19

Compounds for treating cancer

#1390
20180200341
2018-07-19

Hyaluronic acid containing compositions for prevention of the formation of post-surgical scars and post-surgical adhesions

#1391
20180200325
2018-07-19

STABILIZED PEPTIDE COMPOSITION

#1392
20180194803
2018-07-12

Method of treating melanocortin-4 receptor-associated disorders in heterozygous carriers

#1393
20180193495
2018-07-12

POSITRON EMITTING RADIONUCLIDE LABELED PEPTIDES FOR HUMAN UPAR PET IMAGING

#1394
20180193428
2018-07-12

Peptide for promoting bone formation or inhibiting bone resorption and use thereof

#1395
20180193406
2018-07-12

Peptide for skin regeneration or wound treatment and use thereof

#1396
20180186834
2018-07-05

Anti-cancer peptide and use thereof

#1397
20180185436
2018-07-05

Peptide for preventing or treating inflammatory diseases and use thereof

#1398
20180185372
2018-07-05

Use of TREM-1 inhibitors for treatment, elimination and eradication of HIV-1 infection

#1399
20180185302
2018-07-05

METHODS FOR DOWNREGULATING APOBEC3B

#1400
20180179252
2018-06-28

BACE1 inhibitor peptides

#1401
20180177845
2018-06-28

Method for treatment or prevention of a cancer

#1402
20180177842
2018-06-28

Immune system modulators and compositions

#1403
20180177838
2018-06-28

CARBOHYDRATE-BASED PERITONEAL DIALYSIS FLUID COMPRISING GLUTAMINE RESIDUE

#1404
20180177834
2018-06-28

Antiviral methods and compositions comprising probiotic bacterial molecules

#1405
20180171411
2018-06-21

GFRalpha1 AS A BIOMARKER FOR CISPLATIN-INDUCED CHEMORESISTANCE AND METASTASIS

#1406
20180170967
2018-06-21

STAPLED PEPTIDES AND USES THEREOF

#1407
20180170964
2018-06-21

Peptides and analogs for use in the treatment of oral mucositis

#1408
20180170963
2018-06-21

Conotoxin peptide κ-CPTX-BTL04, preparation method therefor, and uses thereof

#1409
20180169248
2018-06-21

Ophthalmic drug delivery system containing phospholipid and cholesterol

#1410
20180169180
2018-06-21

MICAFUNGIN COMPOSITIONS

#1411
20180161390
2018-06-14

Adiponectin peptidomimetics for treating ocular disorders

#1412
20180161389
2018-06-14

R-SPONDIN AGONIST-MEDIATED HAIR GROWTH

#1413
20180155432
2018-06-07

Inhibitors of prototypic galectin dimerization and uses thereof

#1414
20180154006
2018-06-07

Ligand ionophore conjugates

#1415
20180153995
2018-06-07

USE OF ANTIMICROBIAL POLYMERS FOR RE-SENSITIZATION OF MICROORGANISMS UPON EMERGENCE OF RESISTANCE TO ANTI-MICROBIAL AGENTS

#1416
20180153953
2018-06-07

Methods of treating pancreatic cancer using GPCR antagonists

#1417
20180148475
2018-05-31

Cardiovascular Therapeutics

#1418
20180148474
2018-05-31

Peptide derivative for regulating thymic stromal lymphoid protein-mediated signaling and pharmaceutical composition for preventing and treating allergy and asthma diseases comprising same

#1419
20180147252
2018-05-31

Inhibitors of mitochondrial fission and methods of use thereof

#1420
20180141993
2018-05-24

Peptides and combination of peptides for use in immunotherapy against various tumors

#1421
20180141987
2018-05-24

Synthetic antimicrobial peptides

#1422
20180140662
2018-05-24

Sustained Release Formulation Comprising Octreotide and Two or More Polylactide-co-glycolide Polymers

#1423
20180140659
2018-05-24

Analogs of C5a and methods of using same

#1424
20180140658
2018-05-24

Method of treating a wound, comprising the step of administering a composition including a substance P

#1425
20180140657
2018-05-24

Compositions and methods for treating cancer and persistent viral infections

#1426
20180140656
2018-05-24

Short synthetic peptide for the treatment and/or prophylaxis of autoimmune and inflammatory disorders

#1427
20180140562
2018-05-24

Muscular atrophy-inducing agent using hypometabolism-inducing substance T1AM, and use thereof in treating muscular hypertrophy

#1428
20180140545
2018-05-24

ANTIMICROBIAL PEPTIDE STIMULATING SANITIZING COMPOSITION

#1429
20180136218
2018-05-17

Secreted Protein Acidic and Rich in Cysteine (SPARC) Protein SRM/MRM Assay

#1430
20180134752
2018-05-17

PAR1 and PAR2 c-tail peptides and peptide mimetics

#1431
20180134751
2018-05-17

Peptide and its derivatives capable of inhibiting replication of hepatitis V virus in human adipose-derived stem cells and hepatocytes

#1432
20180134750
2018-05-17

Inhibition of gliadin peptides

#1433
20180133340
2018-05-17

Antibody-drug conjugates

#1434
20180133281
2018-05-17

NOVEL INHIBITORS OF MAMMALIAN TIGHT JUNCTION OPENING

#1435
20180126013
2018-05-10

RADIOTHERAPEUTIC AND COMPANION IMAGING AGENTS TO TARGET MC1R

#1436
20180126002
2018-05-10

Methods and compositions for theranostic nanoparticles

#1437
20180125923
2018-05-10

Therapeutic peptides for cerebrovascular diseases

#1438
20180125921
2018-05-10

USE OF QBP1 PEPTIDE FOR THE INHIBITION OF MEMORY CONSOLIDATION

#1439
20180125856
2018-05-10

USE OF GLUCOCORTICOID RECEPTOR ANTAGONIST AND SOMATOSTATIN ANALOGUES TO TREAT ACTH-SECRETING TUMORS

#1440
20180118788
2018-05-03

Influenza virus neutralizing peptidomimetic compounds

#1441
20180118787
2018-05-03

COMPSTATIN ANALOGS FOR TREATMENT OF RHINOSINUSITIS AND NASAL POLYPOSIS

#1442
20180118783
2018-05-03

Peptide with anti-obesity and anti-diabetes activity and use thereof

#1443
20180117113
2018-05-03

Amidated Dopamine Neuron Stimulating Peptide Restoration of Mitochondrial Activity

#1444
20180111963
2018-04-26

Anti-microbial supramolecular structures

#1445
20180111962
2018-04-26

Calcium binding compounds based on gamma-carboxy glutamate

#1446
20180110875
2018-04-26

Anti-c-Met antibody and anti-c-Met antibody-cytotoxic drug conjugate and pharmaceutical use thereof

#1447
20180110846
2018-04-26

IL-23-p19 vaccines

#1448
20180110823
2018-04-26

ENTERICALLY DELIVERED BITTER OLIGOPEPTIDES FOR THE TREATMENT FOR TYPE 2 DIABETES

#1449
20180100005
2018-04-12

Peptides and combination of peptides for use in immunotherapy against various tumors

#1450
20180099993
2018-04-12

Short synthetic peptide for treating diseases and/or conditions related to angiogenesis

#1451
20180094043
2018-04-05

Peptides and combination of peptides for use in immunotherapy against various tumors

#1452
20180085488
2018-03-29

Adhesive peptide and use therefor

#1453
20180085479
2018-03-29

Cathepsin-binding compounds bound to a carrier and their diagnostic use

#1454
20180085423
2018-03-29

METHODS FOR TREATING AND DIAGNOSING EATING DISORDERS

#1455
20180085422
2018-03-29

Compositions for overcoming anti-cancer drug-resistance or compositions for anti-cancer activity employing CAGE-derived peptides

#1456
20180085296
2018-03-29

TRPV3 agonists for the treatment of skin conditions

#1457
20180080452
2018-03-22

Stable liquid formulation of AMG 416 (etelcalcetide)

#1458
20180079792
2018-03-22

Peptide having eight amino acid sequences derived from cage and retaining anticancer activity and activity to promote anticancer drug sensitivity of anticancer drug-resistant cancer cells

#1459
20180079791
2018-03-22

CDCA1-derived peptide and vaccine containing same

#1460
20180078616
2018-03-22

Adiponectin peptidomimetics for treating ocular disorders

#1461
20180078605
2018-03-22

PERIPHERAL KAPPA OPIOID RECEPTOR AGONISTS FOR UREMIC PRURITUS IN DIALYSIS PATIENTS

#1462
20180072782
2018-03-15

Disruption of the WAVE3 protein complex for suppression of invasion and metastasis

#1463
20180072771
2018-03-15

Peptides and compositions comprising same and uses thereof in the treatment of diseases

#1464
20180071399
2018-03-15

Use of single dendritic wedge cell penetrating peptides to facilitate cellular delivery of nanoparticles and nanoparticles carrying cargos

#1465
20180071391
2018-03-15

Topical Pharmaceutical Cosmetic and Disinfectant Compositions Comprising Phosphatidylcholine

#1466
20180071363
2018-03-15

Alpha connexin c-terminal (ACT) peptides and methods of use thereof

#1467
20180066323
2018-03-08

Biomarkers in Cancer, Methods, and Systems Related Thereto

#1468
20180066314
2018-03-08

USE OF TRPC6 MRNA LEVELS IN PERIPHERAL BLOOD CELLS FOR EARLY DETECTION/DIAGNOSIS OF SENILE DEMENTIA

#1469
20180066030
2018-03-08

Method of treating vitiligo using mutant HSP70i

#1470
20180064781
2018-03-08

Sincalide Formulations

#1471
20180057533
2018-03-01

Peptides capable of reactivating p53 mutants

#1472
20180057532
2018-03-01

Peptide having eight amino acid sequences derived from cage and retaining anticancer activity and activity to promote anticancer drug sensitivity of anticancer drug-resistant cancer cells

#1473
20180055856
2018-03-01

Combination of low dose 2-methylene-19-nor-(20S)1α, 25-dihydroxyvitamin Dand calcimimetics to treat secondary hyperparathyroidism

#1474
20180051060
2018-02-22

Cell-permeable (iCP)-SOCS3 recombinant protein and uses thereof

#1475
20180050083
2018-02-22

Compositions and methods for treating and preventing hyperlipidemia, fatty liver, atherosclerosis and other disorders associated with metabolic syndrome

#1476
20180044408
2018-02-15

Anti-ED-A immunoconjugates for inflammatory bowel disease

#1477
20180043030
2018-02-15

Degradable thiol-ene polymers and methods of making thereof

#1478
20180042985
2018-02-15

Methods of improving behavioral therapies

#1479
20180042984
2018-02-15

Pharmaceutical composition for preventing or treating arthritis

#1480
20180037629
2018-02-08

Peptides and combination of peptides for use in immunotherapy against various tumors

#1481
20180037628
2018-02-08

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

#1482
20180037627
2018-02-08

Peptides and combination of peptides for use in immunotherapy against various tumors

#1483
20180037626
2018-02-08

Peptides and combination of peptides for use in immunotherapy against various tumors

#1484
20180036367
2018-02-08

METHODS FOR ATTENUATING RELEASE OF INFLAMMATORY MEDIATORS AND PEPTIDES USEFUL THEREIN

#1485
20180036365
2018-02-08

Composition for preventing, ameliorating, or treating neurological disease containing osmotin peptide as active ingredient

#1486
20180030113
2018-02-01

Peptides and combination of peptides for use in immunotherapy against various tumors

#1487
20180030090
2018-02-01

Non-membrane disruptive P53 activating stapled peptides

#1488
20180028678
2018-02-01

Self-assembling complex for targeting chemical agents to cells

#1489
20180028619
2018-02-01

LKKTET and/or LKKTNT peptide compositions which are lyophilized or in a form capable of being lyophilized

#1490
20180028599
2018-02-01

MCJ agonists and uses therefor

#1491
20180028595
2018-02-01

Compositions and methods for regulating blood pressure

#1492
20180028594
2018-02-01

PERIPHERAL KAPPA OPIOID RECEPTOR AGONISTS FOR HARD TISSUE PAIN

#1493
20180028564
2018-02-01

METHODS FOR PREVENTING OR TREATING INFECTIOUS DISEASES CAUSED BY EXTRACELLULAR MICROORGANISMS, INCLUDING ANTIMICROBIAL-RESISTANT STRAINS THEREOF, USING GALLIUM COMPOUNDS

#1494
20180028449
2018-02-01

Technology for the Preparation of Microparticles

#1495
20180021447
2018-01-25

Lipid Nanoparticle Compositions and Methods of Making and Methods of Using the Same

#1496
20180021430
2018-01-25

SELECTIVE TARGETING OF THE CD40L/MAC-1 INTERACTION BY SMALL PEPTIDE INHIBITORS AND ITS USE FOR THE TREATMENT OF INFLAMMATION AND ATHEROGENESIS

#1497
20180021401
2018-01-25

Compositions and methods for treatment of intracellular damage and bacterial infection

#1498
20180021253
2018-01-25

Peritumoral and intratumoral materials for cancer therapy

#1499
20180015138
2018-01-18

Recovery and processing of human embryos formed in vivo

#1500
20180015137
2018-01-18

Anti-senescence compounds and uses thereof